Physician profile
Sarah Chae
NPI 1003872169
$1,157.24
in general payments reported to CMS, 2019-2025
30 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.58 · 2020: $57.91 · 2022: $101 · 2023: $301 · 2024: $267 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882 · Education: $18.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.50 |
| Education | $18.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $101.32 | 2022-2023 | Ova1 |
| Janssen Biotech, INC. | $98.84 | 2023-2025 | Erleada, Balversa, Akeega |
| Amgen INC. | $86.91 | 2023-2024 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals Lp | $82.89 | 2020-2025 | Airsupra |
| Boston Scientific Corporation | $62.08 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Merck Sharp & Dohme LLC | $57.79 | 2019-2025 | Capvaxive, Gardasil 9 |
| Abbvie INC. | $48.17 | 2024-2025 | |
| Biogen, INC. | $45.34 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $44.02 | 2024-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $43.54 | 2025 | Freestyle Libre 3 |
| Viiv Healthcare Company | $36.81 | 2024 | Cabenuva |
| Medtronic, INC. | $35.63 | 2023 | Interstim |
| Novo Nordisk INC | $34.82 | 2019-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $32.66 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.81 | 2024 | Lifevest |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $27.43 | 2020 | |
| Irhythm Technologies, INC. | $27.32 | 2023 | Zio Xt Patch |
| Allergan, INC. | $25.14 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $23.77 | 2019 | |
| Cardiovascular Systems INC. | $22.78 | 2023 | Diamondback Peripheral |
| Hologic Sales and Service, LLC | $22.00 | 2025 | Myosure Tissue Removal Device |
| Optinose US, INC. | $21.52 | 2019 | |
| Myriad Women'S Health, INC. | $21.18 | 2023 | Myrisk |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.61 | 2023 | Jardiance |
| Astellas Pharma US INC | $19.81 | 2023 | Veozah |
| Regeneron Healthcare Solutions, INC. | $18.99 | 2023 | Evkeeza |
| Redhill Biopharma INC. | $18.02 | 2023 | Talicia |
| Sumitomo Pharma America, INC. | $16.91 | 2025 | Myfembree |
| Takeda Pharmaceuticals U.S.A., INC. | $16.89 | 2024 | Entyvio |
| Lilly USA, LLC | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Chae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.